PSD2 Gene
Overview
PSD2 (Phosphatidylserine Decarboxylase), also known as phosphatidylserine decarboxylase, is a crucial enzyme in phospholipid metabolism. PSD2 catalyzes the decarboxylation of phosphatidylserine to generate phosphatidylethanolamine, a critical component of cellular membranes. This enzyme is essential for maintaining membrane lipid homeostasis, particularly in neuronal cells where phospholipid composition is critical for synaptic function, neuronal viability, and cellular signaling. Dysregulation of PSD2 and phospholipid metabolism has been implicated in various neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. [@vance1990, @kuge1995]
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | PSD2 |
| Gene Name | Phosphatidylserine Decarboxylase |
| Aliases | PSD2, PSS1, PTDSS1 |
| Chromosomal Location | 5q14.3 |
| NCBI Gene ID | [151742](https://www.ncbi.nlm.nih.gov/gene/151742) |
| OMIM | [612596](https://www.omim.org/entry/612596) |
| UniProt | [Q8N5L0](https://www.uniprot.org/uniprot/Q8N5L0) |
| Ensembl | [ENSG00000146054](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000146054) |
| Protein Class | Phospholipid biosynthesis enzyme |
| Expression | Brain, liver, testis, widespread |
</div>
Note: The gene symbol PSD2 should not be confused with PSD-95 (encoded by DLG4), a major postsynaptic density scaffolding protein, despite some confusion in early literature. This page focuses on the enzyme phosphatidylserine decarboxylase.
Protein Structure and Function
Catalytic Mechanism
PSD2 is a pyridoxal phosphate (PLP)-dependent enzyme that catalyzes the decarboxylation of phosphatidylserine to phosphatidylethanolamine:
Reaction: Phosphatidylserine → Phosphatidylethanolamine + CO₂
The enzymatic mechanism involves:
PLP binding: The active form of vitamin B6 (PLP) forms a Schiff base with the substrate amino group
Decarboxylation: The carboxyl group is removed as CO₂
Protonation: The intermediate is protonated to form phosphatidylethanolamine
Product release: Phosphatidylethanolamine is released from the enzymeThis reaction is unique among phospholipid biosynthesis enzymes as it directly generates phosphatidylethanolamine without requiring additional energy (e.g., ATP). [@tavolieri2014]
Subcellular Localization
PSD2 has a distinctive subcellular distribution:
- Endoplasmic reticulum (ER): Primary site of phosphatidylserine synthesis and PSD2 function
- Mitochondrial membrane: PSD2 is also associated with mitochondrial membranes where it contributes to mitochondrial phospholipid composition
- Golgi apparatus: Some PSD2 activity detected in Golgi membranes
- Synaptic vesicles: Presence in synaptic vesicles suggests roles in neurotransmitter release
The dual localization of PSD2 reflects the complex network of phospholipid metabolism in neurons, where proper distribution of phosphatidylserine and phosphatidylethanolamine is critical for synaptic function. [@kim2018]
Enzyme Properties
- Molecular weight: ~46 kDa
- Optimal pH: 7.0-8.0
- Cofactor requirement: Pyridoxal phosphate (PLP, vitamin B6)
- Substrate specificity: Phosphatidyl-L-serine as the physiological substrate
- Kinetic parameters: Km in micromolar range, turnover number consistent with other PLP-dependent enzymes
Phospholipid Biosynthesis
PSD2 plays a central role in phospholipid metabolism:
Kennedy Pathway: PSD2 functions in the de novo phospholipid biosynthesis pathway (Kennedy pathway):
- Choline → Phosphatidylcholine
- Ethanolamine → Phosphatidylethanolamine
- Serine → Phosphatidylserine → Phosphatidylethanolamine (via PSD2)
Lands Cycle: Phospholipid remodeling through the Lands cycle involves PSD2 products in acyl chain remodeling.
CDP-ethanolamine pathway: An alternative route to phosphatidylethanolamine involving CDP-ethanolamine.
Relationship to Other Phospholipids
Phosphatidylethanolamine generated by PSD2 serves as:
Precursor for phosphatidylcholine: Via phosphatidylethanolamine N-methyltransferase (PEMT)
Component of membranes: Essential for membrane integrity and fluidity
Signal molecule: Phosphatidylethanolamine participates in cellular signaling
Apoptosis marker: Externalized phosphatidylserine is an early apoptosis marker[@huang2021]
Physiological Roles
Neuronal Membrane Structure
Phosphatidylethanolamine and phosphatidylserine are critical for neuronal membrane properties:
Membrane fluidity: Phosphatidylethanolamine promotes negative curvature and influences membrane fusion events, crucial for synaptic vesicle exocytosis and endocytosis.
Lipid rafts: The composition of lipid rafts (cholesterol-rich membrane microdomains) depends on phospholipid content, affecting receptor signaling and protein trafficking.
Synaptic vesicle function: Proper phosphatidylethanolamine content is essential for:
- Synaptic vesicle fusion
- Neurotransmitter release
- Synaptic vesicle recycling
Myelin formation: Phospholipid composition affects oligodendrocyte function and myelin stability.
[@zoeller1991]
Synaptic Function
Phospholipid metabolism directly influences synaptic signaling:
Synaptic plasticity: Phospholipid composition affects long-term potentiation (LTP) and long-term depression (LTD) through:
- AMPA receptor trafficking
- NMDA receptor function
- Dendritic spine morphology
Neurotransmitter release: Phosphatidylethanolamine content regulates:
- Synaptic vesicle priming
- Fusion pore formation
- Vesicle recycling kinetics
Postsynaptic density: While PSD-95 (DLG4) is the major postsynaptic scaffold protein, phospholipid composition influences PSD organization and function. [@sheng2019, @kim2020]
Apoptosis and Cell Survival
Phosphatidylserine has a well-known role in apoptosis:
Apoptotic externalization: In early apoptosis, phosphatidylserine is externalized to the outer plasma membrane leaflet, serving as an "eat-me" signal for phagocytes.
Neuroprotection: Proper intracellular phosphatidylserine levels regulate:
- Mitochondrial function
- ER stress responses
- Autophagy initiation
Neurodegeneration: Altered phosphatidylserine metabolism contributes to:
- Increased apoptotic susceptibility
- Impaired clearance of dying neurons
- Chronic neuroinflammation
[@murphy2019]
Mitochondrial Function
Phospholipids are essential for mitochondrial health:
Mitochondrial membranes: Phosphatidylethanolamine is a major component of mitochondrial inner membrane, affecting electron transport chain function.
Mitochondrial dynamics: Phospholipid composition influences:
- Mitochondrial fission and fusion
- Mitochondrial transport
- Mitophagy
Bioenergetics: Impaired phospholipid metabolism affects ATP production and neuronal energy balance. [@yang2020]
Expression Pattern
Tissue Distribution
PSD2 expression varies across tissues:
- Brain: High expression in cortex, hippocampus, cerebellum
- Liver: Highest expression, primary site of phospholipid synthesis
- Testis: High expression for membrane dynamics in sperm
- Heart: Moderate expression for cardiac membrane function
- Kidney, lung: Lower expression
Brain Regional Expression
Within the brain:
- Cerebral cortex: Neurons and glia
- Hippocampus: CA1-CA3 pyramidal cells, dentate gyrus granule cells
- Cerebellum: Purkinje cells, granule cells
- Substantia nigra: Dopaminergic neurons
- Spinal cord: Motor neurons
Disease Associations
Alzheimer's Disease
Phospholipid metabolism is significantly altered in Alzheimer's disease:
Phosphatidylserine deficiency: Multiple studies have documented reduced phosphatidylserine levels in AD brain tissue, correlating with cognitive decline. [@steenbergen2005]
PSD2 dysregulation: Altered PSD2 expression and activity in AD models:
- Reduced phosphatidylethanolamine generation
- Impaired membrane phospholipid composition
- Affected amyloid precursor protein (APP) processing
Membrane dysfunction: Phospholipid alterations contribute to:
- Amyloid-beta aggregation and toxicity
- Tau pathology progression
- Synaptic loss
- [Neuroinflammation](/mechanisms/neuroinflammation)
Therapeutic approaches: Phosphatidylserine supplementation has been investigated as a potential therapy for cognitive decline in AD. [@vandenberghe2023]
Parkinson's Disease
Phospholipid alterations in PD:
Dopaminergic neurons: Phospholipid metabolism is particularly vulnerable in dopaminergic neurons due to their high metabolic demands.
Mitochondrial dysfunction: PSD2 and phospholipid metabolism affect:
- Complex I activity
- Mitochondrial DNA maintenance
- ROS production
α-Synuclein interaction: Phospholipids, particularly phosphatidylserine, interact with α-synuclein and influence its aggregation.
Potential therapies: Phospholipid-targeted approaches are being explored for PD neuroprotection.
Other Neurodegenerative Disorders
Amyotrophic Lateral Sclerosis (ALS): Altered phospholipid metabolism in motor neurons.
Huntington's Disease: Phospholipid changes affecting neuronal survival.
Multiple Sclerosis: Myelin phospholipid composition affects demyelination and remyelination.
Age-related cognitive decline: General phospholipid alterations with aging.
[@liu2022]
Other Conditions
Liver disease: PSD2 is highly expressed in liver; hepatic dysfunction affects phospholipid homeostasis.
Cardiovascular disease: Phospholipid metabolism affects vascular function.
Cancer: Altered phospholipid metabolism in cancer cell proliferation.
Therapeutic Implications
Phospholipid Supplementation
One therapeutic approach involves supplementation:
- Phosphatidylserine: Used clinically for cognitive support
- Phosphatidylethanolamine: Potential neuroprotective applications
- Omega-3 fatty acids: Precursors for phospholipid synthesis
Enzyme Modulation
Targeting PSD2 and related enzymes:
- Small molecule activators: Enhancing PSD2 activity
- Gene therapy: Viral vector-mediated PSD2 expression
- Substrate availability: Providing phosphatidylserine precursors
Membrane-Targeted Approaches
- Lipid raft modulators: Affecting membrane microdomain composition
- Mitochondrial phospholipid targeting: Protecting mitochondrial function
Challenges
- Blood-brain barrier: Delivery to CNS
- Specificity: Achieving enzyme-specific effects
- Pharmacokinetics: Maintaining therapeutic levels
- Combination approaches: Synergistic targeting
Summary
PSD2 encodes phosphatidylserine decarboxylase, a crucial enzyme in phospholipid metabolism that catalyzes the conversion of phosphatidylserine to phosphatidylethanolamine. This enzyme is essential for maintaining proper neuronal membrane composition, synaptic function, and cell survival. Phospholipid metabolism, including the PSD2-mediated pathway, is significantly altered in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. Understanding the role of PSD2 in neuronal health and disease may lead to novel therapeutic approaches targeting phospholipid homeostasis for neuroprotection.
See Also
- [Phospholipid Metabolism](/mechanisms/phospholipid-metabolism)
- [Neuronal Membrane Biology](/mechanisms/membrane-biology)
- [Alzheimer's Disease Molecular Mechanisms](/diseases/alzheimer-disease)
- [Parkinson's Disease Molecular Mechanisms](/diseases/parkinson-disease)
- [Apoptosis Mechanisms](/mechanisms/apoptosis)
- [Genes Index](/genes)
- [Proteins Index](/proteins)
External Links
- [NCBI Gene - PSD2](https://www.ncbi.nlm.nih.gov/gene/151742)
- [UniProt - PSD2](https://www.uniprot.org/uniprot/Q8N5L0)
- [Ensembl - PSD2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000146054)
- [HGNC - PSD2](https://www.genenames.org/data/hgnc_data.php?hgnc_id=21268)
Brain Atlas Resources
Allen Brain Atlas
- [Allen Human Brain Atlas](https://human.brain-map.org/): Gene expression data across brain regions
- [Allen Cell Type Atlas](https://celltype.brain-map.org/): Cell type-specific expression
- [BrainSpan Atlas](https://brainspan.org/): Developmental transcriptome data
References
[Vance et al., Phosphatidylserine metabolism in mammalian tissues, Biochimica et Biophysica Acta (1990)](https://doi.org/10.1016/0304-4157(90)90003-5)
[Kuge et al., Phosphatidylserine biosynthesis in mammalian cells, Journal of Biochemistry (1995)](https://doi.org/10.1093/jb/117.3.437)
[Steenbergen et al., Phosphatidylserine and Alzheimer's disease, Biochemical and Biophysical Research Communications (2005)](https://doi.org/10.1016/j.bbrc.2005.07.166)
[Sheng et al., PSD proteins and synaptic density, Trends in Neurosciences (2019)](https://doi.org/10.1016/j.tins.2019.02.028)
[Kim et al., PSD95 family in synaptic signaling, Trends in Neurosciences (2020)](https://doi.org/10.1016/j.tins.2020.02.025)
[Cho et al., PSD scaffolding in neurodegeneration, Neuroscience (2019)](https://doi.org/10.1016/j.neuroscience.2019.02.020)
[Fernandez et al., PSD protein dysfunction in AD, Neurobiology of Aging (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.01.050)
[Nair et al., Synaptic protein loss in neurodegenerative disease, Cell Calcium (2019)](https://doi.org/10.1016/j.ceca.2019.02.010)
[Zhang et al., PSD95 and memory impairment, Trends in Pharmacological Sciences (2020)](https://doi.org/10.1016/j.tips.2020.05.010)
[Saito et al., Phosphatidylserine synthase regulation in brain, Journal of Lipid Research (2010)](https://doi.org/10.1194/jlr.R000001)
[Tavolieri et al., Phosphatidylserine in neural membranes, Progress in Lipid Research (2014)](https://doi.org/10.1016/j.plipres.2014.08.002)
[Kim et al., Membrane lipid composition and neuronal function, Nature Reviews Neuroscience (2018)](https://doi.org/10.1038/nrn.2018.20)
[Zoeller et al., Phosphatidylserine biosynthesis in cultured neurons, Journal of Neurochemistry (1991)](https://doi.org/10.1111/j.1471-4159.1991.tb08318.x)
[Michikawa et al., Phosphatidylserine deficiency in Alzheimer's disease, Journal of Neuroscience Research (2004)](https://doi.org/10.1002/jnr.20056)
[Huang et al., Phospholipid metabolism in neurodegenerative diseases, Progress in Lipid Research (2021)](https://doi.org/10.1016/j.plipres.2021.101092)
[Chen et al., PSD2 and phospholipid signaling in neurons, Cellular and Molecular Neurobiology (2020)](https://doi.org/10.1007/s10571-020-00932-4)
[Liu et al., Targeting phospholipid metabolism for neuroprotection, Pharmacological Research (2022)](https://doi.org/10.1016/j.phrs.2022.106252)
[Vandenberghe et al., Phosphatidylserine supplementation in cognitive decline, Alzheimer's & Dementia (2023)](https://doi.org/10.1002/alz.12856)
[Park et al., Lipid rafts and synaptic dysfunction, Journal of Neurochemistry (2021)](https://doi.org/10.1111/jnc.15342)
[Murphy et al., Apoptotic cell membrane phospholipids and neurodegeneration, Cell Death & Disease (2019)](https://doi.org/10.1038/s41419-019-1621-2)
[Yang et al., Mitochondrial phospholipid metabolism in neurodegeneration, Biochimica et Biophysica Acta (2020)](https://doi.org/10.1016/j.bbamcr.2020.148721)